Clinical Trial Update: Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process [Phase 1]

View source ↗

Summary

Phase 1 trial comparing insulin aspart produced by the current manufacturing process with the NN2000 process (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED